Preclinical studies show that expression of functional BRCA1 protein in patient-derived xenograft (PDX) models of BRCA1-methylated triple-negative breast cancer can be mediated by BRCA1 hypermethylation loss [42]. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.